Targeted Therapy of AML1/ETO-Positive AML Cells in Experimental Model

被引：0
|
作者：
Zapotocky, Michal [1 ]
Starkova, Julia [1 ]
Mejstrikova, Ester [1 ]
Smetana, Karel [2 ]
Trka, Jan [1 ]
机构：
[1] Charles Univ Prague, Sch Med 2, CLIP, Prague, Czech Republic
[2] Charles Univ Prague, Sch Med 1, Inst Hematol & Blood Transfus, Prague, Czech Republic
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1153 / 1153
页数：1
相关论文
共 50 条
  • [31] THE DIFFERENCES IN PROGNOSTIC OUTCOME BETWEEN AML1/ETO AND CBFβ/MYH11 POSITIVE AML PATIENTS
    Markova, J.
    Michkova, P.
    Maaloufova, J. Soukupova
    Soukup, P.
    Cetkovsky, P.
    Schwarz, J.
    HAEMATOLOGICA, 2012, 97 : 273 - 274
  • [32] Bortezomib-induced down-regulation of KIT is mediated by inhibition of Sp1 and NF-kB in AML1/ETO-positive cells.
    Liu, Shujun
    Pang, Jiuxia
    Yu, Jianhua
    Liu, Zhongfa
    Huynh, Lenguyen
    Kearney, Jessica
    Paschka, Peter
    Klisovic, Rebecca B.
    Baiocchi, Robert
    Blum, William
    Perrotti, Danilo
    Marcucci, Guido
    BLOOD, 2006, 108 (11) : 132B - 132B
  • [33] Molecular Mechanisms of EML in AML1/ETO+ AML and Its Targeting Treatments
    Meng, Fan Yi
    Jiang, Ling
    Zhong, Qingxiu
    Wang, Li Chun
    Yu, Guopan
    Zhu, Xinhua
    BLOOD, 2014, 124 (21)
  • [34] Reversal of p15/INK4b hypermethylation in AML1/ETO-positive and -negative myeloid leukemia cell lines
    Berg, Tobias
    Guo, Yalin
    Abdelkarim, Mahmoud
    Fliegauf, Manfred
    Luebbert, Michael
    LEUKEMIA RESEARCH, 2007, 31 (04) : 497 - 506
  • [35] NHR4 domain mutations of ETO are probably very infrequent in AML1–ETO positive myeloid leukemia cells
    B Hackanson
    M Abdelkarim
    J H Jansen
    M Lübbert
    Leukemia, 2010, 24 : 860 - 861
  • [36] Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells
    Klisovic, MI
    Maghraby, EA
    Parthun, MR
    Guimond, M
    Sklenar, AR
    Whitman, SP
    Chan, KK
    Murphy, T
    Anon, J
    Archer, KJ
    Rush, LJ
    Plass, C
    Grever, MR
    Byrd, JC
    Marcucci, G
    LEUKEMIA, 2003, 17 (02) : 350 - 358
  • [37] PIG 7, TRANSACTIVATED BY AML1, PROMOTES APOPTOSIS OF LEUKEMIA CELLS WITH AML1-ETO FUSION GENE
    Wang, J.
    Liu, J.
    Xing, H.
    Wang, L.
    Wang, D.
    Rao, Q.
    Wang, M.
    EXPERIMENTAL HEMATOLOGY, 2010, 38 (09) : S25 - S25
  • [38] Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials
    Langabeer, SE
    Walker, H
    Rogers, JR
    Burnett, AK
    Wheatley, K
    Swirsky, D
    Goldstone, AH
    Linch, DC
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (04) : 925 - 928
  • [39] Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells
    M I Klisovic
    E A Maghraby
    M R Parthun
    M Guimond
    A R Sklenar
    S P Whitman
    K K Chan
    T Murphy
    J Anon
    K J Archer
    L J Rush
    C Plass
    M R Grever
    J C Byrd
    G Marcucci
    Leukemia, 2003, 17 : 350 - 358
  • [40] CD56+ AML is strongly associated with AML1/ETO rearrangement and CNS involvement in childhood AML
    Lee, Hye Ryun
    Lee, Dong Soon
    Kim, Inho
    Yoon, Sung-Soo
    Park, Seonyang
    Kim, Young Kook
    Kang, Hyoung Jin
    Shin, Hee Young
    Ahn, Hyo Seop
    Kim, Hyun Kyung
    Park, Myoung Hee
    Cho, Han Ik
    BLOOD, 2007, 110 (11) : 136B - 136B
12345